MedTrace Logo

PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers

NCT07144176 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-08-28

No results posted yet for this study

Summary

PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers

Conditions

  • Healthy Subjects

Interventions

DRUG

DWJ1511

Test drug: DWJ1511

DRUG

DWC202501

Comparator: DWC202501

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07144176 on ClinicalTrials.gov